Article Text
Statistics from Altmetric.com
Footnotes
Twitter @janealty1
Contributors SK: writing first draft, revision of manuscript, contribution to figure 1, obtaining patient consent. EV: revision of manuscript, rheumatology expertise, contribution to figure 1. AP: revision of manuscript, ophthalmology expertise, contribution to figure 1. SC: revision of manuscript, neuroradiology expertise; contribution to figure 1. OB: revision of manuscript, ophthalmology expertise, contribution to figure 1. JA: conception of idea, neurologist responsible for overall medical care of patient, revision of manuscript, contribution to figure 1.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests EV has received research grants paid to his employer and consulting fees from Roche and Genentech. JA receives medical textbook royalties from Taylor and Francis, holds shares in ClearSky Medical Diagnostics, has received speaker fees from Allergan & Stada, and advisory board payments from Abbvie and Merz.
Provenance and peer review Not commissioned; externally peer reviewed by Susan Mollan, Birmingham, UK.
Read the full text or download the PDF:
Other content recommended for you
- Idiopathic intracranial hypertension as the initial presentation of systemic lupus erythematosus
- Idiopathic intracranial hypertension as an initial presentation of systemic lupus erythematosus
- Evolving evidence in adult idiopathic intracranial hypertension: pathophysiology and management
- A patient with papilloedema
- Cerebral venous thrombosis: a practical guide
- A practical approach to, diagnosis, assessment and management of idiopathic intracranial hypertension
- Update on the pathophysiology and management of idiopathic intracranial hypertension
- Idiopathic intracranial hypertension is not idiopathic: proposal for a new nomenclature and patient classification
- Drugs used in childhood idiopathic or benign intracranial hypertension
- Idiopathic intracranial hypertension: 12 cases treated by venous sinus stenting